© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Biocon to go Ahead with Syngene IPO, Listing Likely in July
Posted 19th May 2015

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biotechnology major Biocon on Wednesday filed a prospectus with market regulator Securities and Exchange Board of India (Sebi) for the Initial Public Offer (IPO) of its research arm, Syngene, through which it aims to raise around Rs 600 crore for funding research and development (R&D).

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biocon to go Ahead with Syngene IPO, Listing Likely in July

View Biography
Amarchand & Mangaldas

Biopharmaceuticals major Biocon on Tuesday said that the unlocking of the value from its contract research subsidiary Syngene would help the company fund its research and development programmes.

Syngene has already filed the draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), seeking approval for an initial public offering (IPO). The company is estimated to be raising around Rs 600 crore through this public issue.

“We are unlocking value from Syngene to fund our R&D programmes, which include a rich pipeline of biosimilars and novel biologics. This fund infusion will help accelerate these programmes which are at various stages of development currently,” said Kiran Mazumdar-Shaw, chairperson and managing director, Biocon.

This is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene. Biocon along with its subsidiary Biocon Research Limited (BRL), currently holds an 84.5 per cent equity stake in Syngene. The company is offering to sell up to 22 million equity shares of face value of Rs 10 each, through Syngene’s IPO.

The offer includes a reservation of two million equity shares for Biocon’s public equity shareholders, being individuals and Hindu Undivided Families (HUFs). The offer would constitute 11 per cent of the post offer paid-up equity share capital of the company.

Established in 1993, Syngene offers a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. The company’s service offerings also support the development of biosimilar and generic molecules.

During the nine months period-ended December 31, 2014, Syngene serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014.

Syngene had reported revenues of Rs 707.7 crore for the previous financial year-ended March 31, 2014 and Rs 617.5 crore for the nine months period ended December 31, 2014. Earlier this month, the company appointed Peter Bains as its Chief Executive Officer. Bains has been a part of Syngene since January 2010 as a director and has more than two decades of experience in the pharmaceutical space.

“Syngene has a proven track record of providing quality NME discovery, development and manufacturing services. It has long-standing partnerships with three of the world’s leading global healthcare organisations, including Bristol-Myers Squibb Co. and has attracted equity participation from India Value Fund recently, which is reflective of the scale, the value and the quality of the differentiated business model of Syngene,” added Mazumdar-Shaw.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
Silverfleet Acquires Coventya From Equistone
Finance
29/03/2016Silverfleet Acquires Coventya From Equistone

Silverfleet Capital, the European Private Equity firm specialised in buy-to-build, has agreed to acquire a majority stake in Coventya from Equistone Partners Europe Limited for an undisclosed sum.

Read Full PostRead - Eye Icon
Defining the Future of Corporate Digitisation
News
12/03/2024Defining the Future of Corporate Digitisation

Recently anointed as the Best AI-Driven Corporate Advisory Platform 2024 – Global, WebAccountPlus is a company who holds an undeterred desire to pioneer the future of corporate digitisation.

Read Full PostRead - Eye Icon
An Underqualified Workforce: The Impact on Your Business and How to Tackle it
Leadership
03/12/2024An Underqualified Workforce: The Impact on Your Business and How to Tackle it

Stark new statistics reveal that 28% of the UK workforce are underqualified for their jobs across many of the country’s major industries.

Read Full PostRead - Eye Icon
5 Things You Should Know Before Buying Your First Cryptocurrency
News
06/11/20235 Things You Should Know Before Buying Your First Cryptocurrency

Cryptocurrencies are fairly new in the investment world and raise some worry as a result.Plenty of websites offer advice for your first-time crypto purchase. Nonetheless, this remains a rather fresh investment opportunity, bringing along a degree of caution. E

Read Full PostRead - Eye Icon
Innovating Financial Services with Banking APIs
Finance
06/06/2016Innovating Financial Services with Banking APIs

Traditionally, financial services and banking have been among the most conservative industries.

Read Full PostRead - Eye Icon
Winds of Change
Leadership
19/03/2021Winds of Change

Key to a thriving business is the ability of a company to adapt to changing circumstances, but managing this change is never easy. It requires leadership not just to acknowledge the difficulties of upgrading systems, but the value of the people who will run th

Read Full PostRead - Eye Icon
3 Proven Strategies for Mastering the Art of Closing High-Stake M&A Deals
M&A
31/05/20233 Proven Strategies for Mastering the Art of Closing High-Stake M&A Deals

Mergers and acquisitions have always been risky undertakings that can end without profit. The most complex transactions can rightfully involve M&A that can drag on for years without any visible results.

Read Full PostRead - Eye Icon
Technology Transactions
Innovation
29/06/2016Technology Transactions

As with many sectors, the value of technology transactions was impressive during the second half of 2015. In all USD 319,086 million-worth of deal making was recorded over the six months.

Read Full PostRead - Eye Icon
A Good Reason to Follow the Law – What Attorneys Can Teach Us About SEO
Legal
28/02/2023A Good Reason to Follow the Law – What Attorneys Can Teach Us About SEO

Marketers already know how important search engine optimization (SEO) is for growing your small business, but you may not think of attorneys as experts in SEO.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow